ADD WEBEX/TEAMS LINK

Microsoft Teams meeting

Join on your computer or mobile app

Click here to join the meeting

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Determine whether biliary atresia is a disease that deserves a newborn screen.
2. Evaluate a new screening test for biliary atresia.

FACULTY DISCLOSURE:  Dr. Sanjib Harpavat has a relevant financial relationship with Syneos Health in the form of honorarium as a DSMB member for a therapeutic trial for Biliary Atresia.

PLANNERS DISCLOSURES:  Dr. Christopher Hovland and Dr. Muralidhar Jatla do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABP MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.